Protein carbonyls and lipid peroxidation products as oxidation markers in preterm infant plasma: Associations with chronic lung disease and retinopathy and effects of selenium supplementation

Pediatric Research

Volumn 48, Issue 1, 2000, Pages 84-90

  Winterbourn, Christine C ^a   Chan, Timothy ^a   Buss, I Hendrikje ^a   Inder, Terrie E ^a   Mogridge, N ^a   Darlow, Brian A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL DERIVATIVE; MALONALDEHYDE; PROTEIN DERIVATIVE; SELENATE; SODIUM SELENITE;

ARTICLE; CHRONIC LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SCREENING; HUMAN; INFANT; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PREMATURITY; PRIORITY JOURNAL; PROTEIN DETERMINATION; RANDOMIZED CONTROLLED TRIAL; RETINOPATHY; TREATMENT OUTCOME; VERY LOW BIRTH WEIGHT;

EID: 0033918120     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200007000-00015     Document Type: Article

References (54)

1. Saugstad OD 1996 Mechanisms of tissue injury by oxygen radicals: implications for neonatal disease. Acta Paediatr 85:1-4
2. Zimmerman JJ 1995 Bronchoalveolar inflammatory pathophysiology of bronchopulmonary dysplasia. Clin Perinatol 22:429-457
3. Merritt TA, Stuard ID, Puccia J, Wood B, Edwards DK, Finkelstein J, Shirpiro DL 1981 Newborn tracheal aspirate cytology: classification during respiratory distress syndrome and bronchopulmonary dysplasia. J Pediatr 98:949-956
4. Groneck P, Gotze-Speer B, Opperman M, Eiffert H, Speer CP 1994 Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high risk preterm neonates. Pediatrics 93:712-718
5. Groneck P, Speer CP 1995 Inflammatory mediators and bronchopulmonary dysplasia. Arch Dis Child 73:F1-F3
6. Contreras M, Hariharan N, Lewandoski JR, Ciesielski W, Koscik R, Zimmerman JJ 1996 Bronchoalveolar oxyradical inflammatory elements herald bronchopulmonary dysplasia. Crit Care Med 24:29-37
7. Saugstad OD 1997 Bronchopulmonary dysplasia and oxidative stress: are we closer to an understanding of the pathogenesis of BPD? Acta Paediatr 86:1277-1282
8. Rao RA 1996 Oxygen free radicals and retinopathy of prematurity. Brit J Opthalmol 80:387
9. Kelly FJ 1993 Free radical disorders of preterm infants. Br Med Bull 49:668-678
10. Inder TE, Darlow BA, Sluis KB, Winterboum CC, Graham P, Sanderson K, Taylor BJ 1996 The correlation of elevated levels of an index of lipid peroxidation (MDA-TBA) with adverse outcome in the very low birth weight infant. Acta Paediatr 85:1116-1122
11. Inder TE, Graham P, Sanderson KJ, Taylor BJ 1994 Lipid peroxidation as a measure of oxygen free radical damage in the very low birth weight infant. Arch Dis Child 70:F107-F111
12. Schmidt H, Grune T, Mueller R, Siems WG, Wauer RR 1996 Increased levels of lipid peroxidation products malondialdehyde and 4-hydroxynonenal after perinatal hypoxia. Pediatr Res 40:15-20
13. Banks BA, Ischiropoulos H, McClelland M, Ballard PL, Ballard RA 1998 Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia. Pediatrics 101:870-874
14. Drury JA, Nycyk JA, Cooke RW 1997 Comparison of urinary and plasma malondialdehyde in preterm infants. Clin Chim Acta 263:177-185
15. Lubec G, Widnes JA, Hayde M, Menzel D, Pollak A 1997 Hydroxyl radical generation in oxygen-treated infants. Pediatrics 100:700-704
16. Schlenzig JS, Bervoets K, von Loewenich V, Boehles H 1993 Urinary malondialdehyde concentration in preterm neonates: is there a relationship to disease entities of neonatal intensive care? Acta Paediatr 82:202-205
17. Gladstone Jr IM, Levine RL 1994 Oxidation of proteins in neonatal lungs. Pediatrics 93:764-768
18. Varsila E, Pesonen E, Andersson A 1995 Early protein oxidation in the neonatal lung is related to development of chronic lung disease. Acta Paediatr 84:1296-1299
19. Wispe JR, Bell EF, Roberts RJ 1985 Assessment of lipid peroxidation in newborn infants and rabbits by measurements of expired ethane and pentane: influence of parenteral lipid infusion. Pediatr Res 19:374-379
20. Pitkänen OM, Hallman M, Andersson SM 1990 Correlation of free oxygen radical-induced lipid peroxidation with outcome in very low birth weight infants. J Pediatr 116:760-764
21. Varsila E, Hallman M, Andersson S 1994 Free-radical-induced lipid peroxidation during the early neonatal period. Acta Paediatr 83:692-695
22. Varsila E, Pitkanen O, Hallman M, Andersson S 1994 Immaturity-dependent free radical activity in premature infants. Pediatr Res 36:55-59
23. Nycyk JA, Drury JA, Cooke RW 1998 Breath pentane as a marker for lipid peroxidation and adverse outcome in preterm infants. Arch Dis Child Fetal Neonatal Ed 79:F67-F69
24. Smith CV, Hansen TN, Martin NE, McMicken HW, Elliott SJ 1993 Oxidant stress responses in premature infants during exposure to hyperoxia. Pediatr Res 34:360-365
25. Rogers MS, Mongelli JM, Tsang KH, Wang CC, Law KP 1998 Lipid peroxidation in cord blood at birth: the effect of labour. Br J Obstet Gynaecol 105:739-744
26. Buonocore G, Zani S, Perrone S, Caciotti B, Bracci R 1998 Intraerythrocyte nonprotein-bound iron and plasma malondialdehyde in the hypoxic newborn. Free Radic Biol Med 25-766-770
27. Raju TNK, Langenberg P, Bhutani V, Quin GE 1997 Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials. J Pediatr 131:844-850
28. Ehrenkranz RA, Mercurio MR 1992 Bronchopulmonary dysplasia. In: Sinclair JC, Bracken MB (eds) Effective Care of the Newborn Infant. Oxford University Press, Oxford, pp 399-424
29. Levander OA 1987 A global view of human selenium nutrition. Ann Rev Nutr 7:227-250
30. Lockitch G, Jacobson B, Quigley G, Dison P, Pendray M 1988 Selenium deficiency in low birth weight neonates: an unrecognized problem. J Pediatr 114:865-870
31. Sluis KB, Darlow BA, George PM, Mogridge N, Dolamore BA, Winterbourn CC 1992 Selenium and glutathione peroxidase levels in premature infants in a low selenium community (Christchurch, New Zealand). Pediatr Res 32:189-194
32. Darlow BA, Inder TE, Graham PJ, Sluis KB, Malpas TJ, Taylor BJ, Winterbourn CC 1995 Selenium status in the very low birth weight infant: relationship to maternal status infant nutrition and respiratory outcome. Pediatrics 96:314-319
33. Darlow BA, Winterbourn CC, Inder TE, Graham PJ, Harding JE, Weston PJ, Austin NC, Elder DE, Mogridge N, Buss IH, Sluis KB 2000 The effect of selenium supplementation on outcome in very low birth weight infants: a randomized controlled trial. J Pediatr 136:473-480
34. Janero DR 1990 Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 9:515-540
35. Buss H, Chan TP, Sluis KB, Domigan NM, Winterbourn CC 1997 Protein carbonyl measurement by a sensitive ELISA method. Free Radic Biol Med 23:361-366
36. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz A-G, Ahn B-W, Shalteil S, Stadtman ER 1990 Determination of carbonyl content of oxidatively modified proteins. Methods Enzymol 186:464-478
37. Reznick AZ, Cross CE, Hu ML, Suzuki YJ, Khwaja S, Safadi A, Motchnik PA, Packer L, Halliwell B 1992 Modification of plasma proteins by cigarette smoke as measured by protein carbonyl formation. Biochem J 286:607-611
38. Wong SHY, Knight JA, Hopfer SM, Zaharia O, Leach Jr CN, Sunderman Jr FW 1987 Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 33:214-220
39. Young IS, Trimble ER 1991 Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann Clin Biochem 28:504-508
40. Jaskot RH, Charlet EG, Grose EC, Grady MA, Roycroft JH 1983 An automated analysis of glutathione peroxidase, S-transferase, and reductase activity in animal tissue. J Anal Toxicol 7:86-88
41. Wade CR, van Rij AM 1988 Plasma thiobarbituric acid reactivity: reaction conditions and the role of iron, antioxidants and lipid peroxy radicals on the quantitation of plasma lipid peroxides. Life Sci 43:1085-1093
42. Darlow BA, Clemett RS 1990 Retinopathy of prematurity; screening and optimal usage of the ophthalmologists time. Aust N Z J Opthalmol 18:41-46
43. Committee for the Classification of Retinopathy of Prematurity 1984 An international classification of retinopathy of prematurity. Pediatrics 74:127-133
44. Wade CR, Jackson PG, van Rij AM 1985 Quantitation of malondialdehyde (MDA) in plasma, by ion-pairing reverse phase high performance liquid chromatography. Biochem Med 33:291-296
45. Bowry VW, Stanley KK, Stocker R 1992 High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc Natl Acad Sci U S A 89:10316-10320
46. Smith MA, Perry G, Sayre LM, Anderson VE, Beal MF, Kowalll N 1996 Oxidative damage in Alzheimer's. Nature 382:120-121
47. Ciolino HP, Levine RL 1997 Modification of proteins in endothelial cell death during oxidative stress. Free Radic Biol Med 22:1277-1282
48. Winterbourn CC, Buss IH, Chan TP, Plank LD, Clark MA, Windsor JA 2000 Protein carbonyl measurements show evidence of early oxidative stress in critically ill patients. Crit Care Med 28:143-149
49. Draper HH, Hadley M 1990 Malondialdehyde determination as an index of lipid peroxidation. Methods Enzymol 186:421-431
50. Buss IH, Darlow BA, Winterbourn CC 2000 Elevated protein carbonyls and lipid peroxidation products correlating with myeloperoxidase in tracheal aspirates from premature infants. Pediatr Res 47:640-645
51. Morrow JD, Roberts LJ 1997 The isoprostanes: current knowledge and directions for future research. Biochem Pharmacol 51:1-9
52. Berger TM, Polidori MC, Dabbagh A, Evans PJ, Halliwell B, Morrow JD, Roberts LJ, Frei B 1997 Antioxidant activity of vitamin C in iron-overloaded human plasma. J Biol Chem 272:15656-15660
53. Murch SH, Costeloe K, Klein NJ, MacDonald TT 1996 Early production of macrophage inflammatory protein-1 alpha occurs in respiratory distress syndrome and is associated with poor outcome. Pediatr Res 40:490-497
54. Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, Kim BI 1997 Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, Kim BI. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1b, and interleukin-8) and the risk of development of bronchopulmonary dysplasia. Am J Obstet Gynecol 177:825-830